Alaunos Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Alaunos Therapeutics, Inc. (TCRT) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $9.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-14
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $9.00K.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $19.00K.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $31.00K.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $12.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2026-06-30 | $9.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $19.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $31.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $12.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $69.02M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-14 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $45.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $364.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $3.00K 10-K · filed 2025-03-31 |
| 2022-09-30 | $3.57M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.61M 10-Q · filed 2022-08-15 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-30 |
| 2021-09-30 | $473.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $899.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $4.93M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $812.00K 10-K · filed 2021-03-01 |
| 2020-09-30 | $978.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.90M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $864.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $7.48M 10-K · filed 2020-03-02 |
| 2019-09-30 | $6.03M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $12.46M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $5.49M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $88.00K 10-K · filed 2019-03-05 |
| 2018-09-30 | $576.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $415.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.02M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.15M 10-K · filed 2018-03-01 |
| 2017-09-30 | $5.66M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $5.88M 10-Q · filed 2017-07-31 |
| 2017-03-31 | $6.29M 10-Q · filed 2017-05-01 |
| 2016-12-31 | $3.41M 10-K · filed 2017-02-16 |
| 2016-09-30 | $4.32M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $4.05M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $9.87M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $12.60M 10-K · filed 2016-02-24 |
| 2015-09-30 | $16.48M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $27.53M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $39.56M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $9.08M 10-K · filed 2015-02-26 |
| 2014-09-30 | $1.46M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $4.46M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $6.46M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $5.34M 10-K · filed 2014-03-03 |
| 2013-09-30 | $4.25M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $956.00K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $801.00K 10-Q · filed 2013-05-07 |
| 2012-12-31 | $3.97M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |